• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about FDA

Recent news which mentions FDA

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
What's Going With COVID-19 Test Maker QuidelOrtho Stock On Tuesday?
April 02, 2024
Tickers NEWS QDEL
Tags Briefs Expert Ideas General
From Benzinga
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries
April 02, 2024
Tickers ABT NEWS
Tags Health Care ABT FDA
From Benzinga
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
April 01, 2024
Tickers BAX NEWS
Tags Briefs Equities why it's moving
From Benzinga
FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare Disease
April 01, 2024
Tickers APLT NEWS
Tags Trading Ideas Health Care FDA
From Benzinga
4D Molecular Therapeutics Outlines Pivotal Development Plans For Cystic Fibrosis, Rare Inherited Disease
March 28, 2024
Tickers FDMT NEWS
Tags Briefs FDMT why it's moving
From Benzinga
FDA Approves For Akebia Therapeutics' Vafseo For Kidney Disease Associated Anemia
March 28, 2024
Tickers AKBA NEWS
Tags General News why it's moving
From Benzinga
Medtronic's Latest Generation Of Transcatheter Aortic Valve Replacement Implant Passes FDA's Muster, Shares Gain
March 27, 2024
Tickers MDT NEWS
Tags Stories That Matter FDA Health Care
From Benzinga
The Most Important Catalyst For Merck's Stock In 2024 Could Be Sotatercept Launch, Analyst Says
March 27, 2024
Tickers MRK NEWS
Tags MRK Expert Ideas Briefs
From Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
March 27, 2024
Tickers MNMD NEWS
Tags Interview News Psychedelics
From Benzinga
Merck's $11B Bet Pays As FDA Approves Sotatercept For Rare Lung Disease
March 27, 2024
Tickers BMY MRK NEWS
Tags Benzinga Movers Biotech
From Benzinga
After Almost 4 Years, FDA Says Mesoblast Phase 3 Therapy Data Can Support Resubmission For Serious Complications in Children Following Stem Cell Transplant
March 26, 2024
Tickers MESO NEWS
Tags Health Care FDA Stories That Matter
From Benzinga
Elon Musk-Backed Brain Chip Implant Neuralink Under Scrutiny Lens Following FDA's Oversight Regulatory Compliance
March 26, 2024
Tickers AIEQ BKES NEWS QRFT
Tags Large Cap Neuralink News
From Benzinga
Stoke Therapeutics' Anti-Epilepsy Drug Candidate Shows Substantial, Sustained Reductions In Seizure Frequency In Pretreated Patients
March 26, 2024
Tickers NEWS STOK
Tags Health Care Trading Ideas STOK
From Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers NEWS NUMIF
Tags News Psychedelics Research Psychedelics
From Benzinga
Nova Biomedical New Generation StatStrip Glucose Hospital Meter Obtains FDA 510k Clearance
March 25, 2024
Tickers ICU
Tags Biotech United States Hospital
From PRLog
FDA Delays Decision For Regeneron's Inaugural Blood Cancer Therapy, Highlights Trial Concerns
March 25, 2024
Tickers NEWS REGN
Tags FDA Briefs Health Care
From Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap